Ask AI
Obesity Management in HFpEF

CE / CME

Obesity Management in a Patient With HFpEF

Physician Assistants/Physician Associates: 0.50 AAPA Category 1 CME credit

Nurse Practitioners/Nurses: 0.50 Nursing contact hour

Physicians: maximum of 0.50 AMA PRA Category 1 Credit

Released: October 03, 2025

Expiration: October 02, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

Your patient is a 62-year-old man with established heart failure with preserved ejection fraction (HFpEF) (ejection fraction 70%) and obesity (BMI 38 kg/m2, weight-to-height ratio 0.6), but he does not have diabetes. He has made an appointment to discuss worsening shortness of breath and edema. You engage him in a discussion on weight loss, and he is open to trying an antiobesity medication (AOM). Based on current American College of Cardiology (ACC) and American Association of Clinical Endocrinology (AACE) guidance, what would you recommend as optimal AOM options?

2.

Which best represents evidence supporting recommendations for the preferred use of certain incretin-based AOMs for obesity management in HFpEF?